International Journal of Molecular Medical Science, 2024, Vol.14, No.6, 355-368 http://medscipublisher.com/index.php/ijmms 365 Fang T., Je G., Pacut P., Keyhanian K., Gao J., and Ghasemi M., 2022, Gene therapy in amyotrophic lateral sclerosis, Cells, 11(13): 2066. https://doi.org/10.3390/cells11132066 PMid:35805149 PMCid:PMC9265980 Fenoglio C., Scarpini E., Serpente M., and Galimberti D., 2018, Role of genetics and epigenetics in the pathogenesis of Alzheimer’s disease and frontotemporal dementia1, Journal of Alzheimer's Disease, 62: 913-932. https://doi.org/10.3233/JAD-170702 PMid:29562532 PMCid:PMC5870004 Freudenberg-Hua Y., Li W., and Davies P., 2018, The role of genetics in advancing precision medicine for Alzheimer’s disease-a narrative review, Frontiers in Medicine, 5: 108. https://doi.org/10.3389/fmed.2018.00108 PMid:29740579 PMCid:PMC5928202 Gallardo G., and Holtzman D., 2019, Amyloid-β and tau at the crossroads of Alzheimer's disease, Advances in Experimental Medicine and Biology, 1184: 187-203. https://doi.org/10.1007/978-981-32-9358-8_16 PMid:32096039 Galluzzi S., Mega A., Fede G., Muscio C., Fascendini S., Benussi L., Tagliavini F., Frisoni G., and Maria E., 2022, Psychological impact of predictive genetic testing for inherited Alzheimer disease and frontotemporal dementia, Alzheimer Disease and Associated Disorders, 36: 118-124. https://doi.org/10.1097/WAD.0000000000000494 PMid:35293381 PMCid:PMC9132242 Ghaffari M., Sanadgol N., and Abdollahi M., 2020, A systematic review of current progresses in the nucleic acid-based therapies for neurodegeneration with implications for Alzheimer's disease, Mini Reviews in Medicinal Chemistry, 20(15): 1499-1517. https://doi.org/10.2174/1389557520666200513122357 PMid:32400332 Greaves C., and Rohrer J., 2019, An update on genetic frontotemporal dementia, Journal of Neurology, 266: 2075-2086. https://doi.org/10.1007/s00415-019-09363-4 PMid:31119452 PMCid:PMC6647117 Guerreiro R., Gibbons E., Tábuas-Pereira M., Kun-Rodrigues C., Santo G., and Bras J., 2020, Genetic architecture of common non-Alzheimer’s disease dementias, Neurobiology of Disease, 142: 104946. https://doi.org/10.1016/j.nbd.2020.104946 PMid:32439597 PMCid:PMC8207829 Guerreiro R., Ross O., Kun-Rodrigues C., Hernandez D., Orme T., Eicher J., Shepherd C., Parkkinen L., Darwent L., Heckman M., Scholz S., Troncoso J., Pletnikova O., Ansorge O., Clarimón J., Lleó A., Morenas-Rodriguez E., Clark L., Honig L., Marder K., Lemstra A., Rogaeva E., George-Hyslop P., Londos E., Zetterberg H., Barber I., Braae A., Brown K., Morgan K., Troakes C., Al-Sarraj S., Lashley T., Holton J., Compta Y., Deerlin V., Serrano G., Beach T., Lesage S., Galasko D., Masliah E., Santana I., Pastor P., Diez-Fairen M., Aguilar M., Tienari P., Myllykangas L., Oinas M., Révész T., Lees A., Boeve B., Petersen R., Ferman T., Escott-Price V., Graff-Radford N., Cairns N., Morris J., Pickering-Brown S., Mann D., Halliday G., Hardy J., Trojanowski J., Dickson D., Singleton A., Stone D., and Bras J., 2018, Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study, The Lancet Neurology, 17(1): 64-74. https://doi.org/10.1016/S1474-4422(18)30399-5 PMid:30507384 Guo T., Zhang D., Zeng Y., Huang T., Xu H., and Zhao Y., 2020, Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease, Molecular Neurodegeneration, 15: 1-37. https://doi.org/10.1186/s13024-020-00391-7 PMid:32677986 PMCid:PMC7364557 Hanafy A., Schoch S., and Lamprecht A., 2020, CRISPR/Cas9 delivery potentials in Alzheimer’s disease management: a mini review, Pharmaceutics, 12(9): 801. https://doi.org/10.3390/pharmaceutics12090801 PMid:32854251 PMCid:PMC7559557 Hansen D., Hanson J., and Sheng M., 2018. Microglia in Alzheimer’s disease, The Journal of Cell Biology, 217: 459-472. https://doi.org/10.1083/jcb.201709069 PMid:29196460 PMCid:PMC5800817 Hausman-Cohen S., Bilich C., Kapoor S., Maristany E., Stefani A., and Wilcox A., 2022, Genomics as a clinical decision support tool for identifying and addressing modifiable causes of cognitive decline and improving outcomes: proof of concept support for this personalized medicine strategy, Frontiers in Aging Neuroscience, 14: 862362. https://doi.org/10.3389/fnagi.2022.862362 PMid:35517054 PMCid:PMC9062132 Heart C.G., Ad E., Genetic P., et al., 2019, Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing, Nature Genetics, 51: 414-430. https://doi.org/10.1038/S41588-019-0358-2
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==